Search Within

Lymphoma

Formats
  1. Meeting Abstract (1382)
  2. Journal Article (1056)
  3. Book Section (64)
  4. Review (64)
  5. Editorial (38)
  6. Research Letter (38)
  7. Guidelines (18)
  8. Conference Paper (15)
  9. Correspondence (11)
  10. Miscellaneous (5)
  11. Book Whole (4)
Groups
  1. Center for Hematologic Malignancies (2695)
  2. Department of Medicine (2695)
  3. Hematologic Malignancies, Division of (2695)
  4. Population Sciences Research Program (742)
  5. Survivorship Research (655)
  6. Executive Committee, Center for Hematologic Malignancies (391)

More Groups

People
  1. Andrew Zelenetz (781)
  2. Steven Horwitz (664)
  3. Maria Palomba (444)
  4. Ariela Noy (369)
  5. David Straus (360)
  6. Alison Moskowitz (355)

More People

Years
  1. 2025 (42)
  2. 2024 (141)
  3. 2023 (180)
  4. 2022 (170)
  5. 2021 (171)
  6. 2020 (170)

More Years

Publications
  1. Blood (876)
  2. Journal of Clinical Oncology (277)
  3. Hematological Oncology (110)
  4. British Journal of Haematology (81)
  5. Leukemia and Lymphoma (81)
  6. Haematologica (71)

More Publications

Publishers
  1. American Society of Hematology (941)
  2. American Society of Clinical Oncology (293)
  3. Elsevier Inc. (187)
  4. Wiley Blackwell (174)
  5. John Wiley & Sons (96)
  6. Nature Publishing Group (93)

More Publishers

Results (2695)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): Part II. Prognosis, management, and future directions
    Journal Article

    Jawed, S. I.; Myskowski, P. L.; Horwitz, S.; Moskowitz, A.; Querfeld, C.
    Journal of the American Academy of Dermatology (2014)

    Fulltext@MSK | Save
  • Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): Part I. Diagnosis: Clinical and histopathologic features and new molecular and biologic markers
    Journal Article

    Jawed, S. I.; Myskowski, P. L.; Horwitz, S.; Moskowitz, A.; Querfeld, C.
    Journal of the American Academy of Dermatology (2014)

    Fulltext@MSK | Save
  • Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: Pivotal study update demonstrates durable responses
    Journal Article

    Coiffier, B.; Pro, B.; Prince, H. M.; Foss, F.; Sokol, L.; Greenwood, M.; Caballero, D.; Morschhauser, F.; Wilhelm, M.; Pinter-Brown, L.; more...
    Journal of Hematology & Oncology (2014)

    Fulltext@MSK | Save
  • Phase IA/II, multicentre, open-label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non-Hodgkin or Hodgkin lymphoma
    Journal Article

    Fanale, M.; Assouline, S.; Kuruvilla, J.; Solal-Céligny, P.; Heo, D. S.; Verhoef, G.; Corradini, P.; Abramson, J. S.; Offner, F.; Engert, A.; more...
    British Journal of Haematology (2014)

    Fulltext@MSK | Save
  • Brentuximab vedotin for the treatment of patients with hodgkin lymphoma
    Journal Article

    Younes, A.
    Hematology/Oncology Clinics of North America (2014)

    Fulltext@MSK | Save
  • SGN-75 in the treatment of patients with CD70-positive malignancies including metastatic renal cell carcinoma
    Meeting Abstract

    Thompson, J. A.; Forero, A.; Heath, E. I.; Pal, S. K.; Ansell, S. M.; Infante, J. R.; De Vos, S.; Hamlin, P. A.; Whiting, N. C.; Zhao, B.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Infectious disease associations in advanced stage, indolent lymphoma (follicular, FL, and nonfollicular, nFL): A prospective trial of antibiotic therapy
    Meeting Abstract

    Portlock, C. S.; Hamlin, P. A.; Gerecitano, J. F.; Noy, A.; Palomba, M. L.; Walkley, J.; Corcoran, S.; Papanicolaou, G. A.; Markowitz, A.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Preliminary safety and efficacy of IPI-145, a potent inhibitor of phosphoinositide-3-kinase-δ,γ, in patients with relapsed/refractory CLL
    Meeting Abstract

    Patel, M. R.; Kahl, B. S.; Horwitz, S. M.; Younes, A.; Foss, F. M.; Oki, Y.; Sweeney, J.; Allen, K.; Faia, K.; Kelly, P. F.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Belinostat, a novel pan-histone deacetylase inhibitor (HDACi), in relapsed or refractory peripheral T-cell lymphoma (R/R PTCL): Results from the BELIEF trial
    Meeting Abstract

    O'Connor, O. A.; Masszi, T.; Savage, K. J.; Pinter-Brown, L. C.; Foss, F. M.; Popplewell, L.; Cashen, A. F.; Doorduijn, J.; Chawla, S.; Knoblauch, P.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase II study of the selective phosphatidylinositol 3-kinase delta (PI3Kδ) inhibitor idelalisib (GS-1101) in combination with rituximab (R) in treatment-naive patients (pts) ≥ 65 years with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)
    Meeting Abstract

    O'Brien, S. M.; Lamanna, N.; Kipps, T. J.; Flinn, I.; Zelenetz, A. D.; Burger, J. A.; Holes, L.; Johnson, D. M.; Gu, J.; Dansey, R. D.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save